Last reviewed 2026-04-20 · How we verify

TAURINE

FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	TAURINE
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study). (NA)
Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS) (PHASE1)
Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis (PHASE2)
Taurine Supplementation in Long COVID (PHASE2, PHASE3)
Low-Dose Caffeine and Taurine Effects on Performance (NA)
Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine. (PHASE2)
Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder (PHASE4)
Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results